Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
The prospect of combining genomically targeted therapies with drugs that free the immune system to attack cancer suggests "we are finally poised to ...
Humans don't have to worry about getting cancer from the leukemic clams, Gerwick said. The immune system in people would attack any leukemic ...
They looked for indicators of tumor growth and at markers of the immune system'sresponse to the cancer. In tumors with mutations in the NRAS gene, ...
People with high-risk tumors containing BRAF or NRAS gene mutations have lower survival rates - News-Medical.net
Study Supports Laparoscopic Surgery for Rectal Cancer
Patients who had either laparoscopic surgery or open surgery for localized rectal cancer had similar overall survival and disease-free survival rates.
Patients who had either laparoscopic surgery or open surgery for localized rectal cancer had similar overall survival and disease-free survival rates.
Diabetics at Increased Risk of Advanced Breast Cancer
Women with diabetes are at a greater risk of being diagnosed with advanced-stage breast cancer, according to a retrospective study.
Women with diabetes are at a greater risk of being diagnosed with advanced-stage breast cancer, according to a retrospective study.
PARK2 Mutation Linked to Lung Cancer Risk
Through whole-exome sequencing, researchers for the first time have identified a link between a mutation in PARK2, a gene associated with early-onset Parkinson's disease and familial lung cancer.
Through whole-exome sequencing, researchers for the first time have identified a link between a mutation in PARK2, a gene associated with early-onset Parkinson's disease and familial lung cancer.
Science Daily Cancer News
In comparison with watchful waiting, the new drug Enzalutamide can prolong survival in certain patients with prostate cancer and delay the occurrence of disease complications, a new study concludes.
A mother who has tested positive for the BRCA2 cancer gene is one of 12 people in her family over three generations linked to the gene or diagnosed with cancer. Now she is using her family’s genetic history to contribute to cancer research, prevention and treatment – with the aim of improving the quality of life for those facing hereditary risk.
A family of proteins called G proteins are a recognized component of the communication system the human body uses to sense hormones and other chemicals in the bloodstream and to send messages to cells. In work that further illuminates how cells work, researchers have discovered a new role for G proteins that may have relevance to halting solid tumor cancer metastasis.
Resistance to therapy is a major problem in the cancer field. Using human cell lines of the HER2-positive breast cancer subtype, researchers detailed the surprising ways in which resistance to the drug lapatinib manifests and how to defeat resistance before it happens.
Using induced pluripotent stem cells (iPSCs), a team of researchers has gained new insight into genetic changes that may turn a well known anti-cancer signaling gene into a driver of risk for bone cancers. The findings revolve around iPSCs, which since their 2006 discovery have enabled researchers to coax mature (fully differentiated) bodily cells (e.g. skin cells) to become like embryonic stem cells. Such cells are pluripotent, able to become many cell types as they multiply and differentiate to form tissues. The iPSCs can then be converted again as needed into differentiated cells such as heart muscle, nerve cells, bone, etc.
Tambahkan Komentar